Some New Development I P C Meeting Copenhagen through VC Zafar Mirza 18 June 2015 Brussels WHOEC Project Improving access to medical products in developing countries through building capacity for local production and related technology transfer ID: 754249
Download Presentation The PPT/PDF document "Improving access to medicines through lo..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Improving access to medicines through local production:
Some New Development
I P C Meeting, Copenhagen (through VC)
Zafar Mirza
18 June 2015, Brussels Slide2
WHO/EC Project:
“Improving access to medical products in developing countries through building capacity for local production and related technology transfer”
Phase I -
Identified main trends and barriers to local production of pharmaceuticals, vaccines and diagnostics. Published 8 reports. (2009-2011)
Phase II - Activities to promote greater policy coherence between government policies that affect the local production in order to improve access. (2012-2014)Slide3
"We
welcome the surge of interest in the manufacturing of essential health technologies in Africa.
"
"UNAIDS
, UNIDO and WHO are working closely with the AUC to better coordinate inter-agency efforts to support African governments
."
"Africa’s
development partners, especially the BRICS countries (Brazil, the Russian Federation, India, China and South Africa), have a special role in supporting this critical phase of African development
."
WHO Bulletin, June 2014Slide4
WHO Director General's Strategic Grant for local production
To work with AUC and other development partners for implementation of P
pharmaceutical Manufacturing Plan for Africa (Business Plan)Provide assistance to countries on request in strengthening their pharmaceutical production for improving accessSlide5
Framework for Local Production for Improving Access
INDUSTRIAL
POLICY
Competitive
Reliable
Innovative
Productive
Responsible
Strategic
HEALTH
POLICY
Access
(Availability
Affordable)
Quality
Supply
Rational Use
SHARED GOALS HEALTH +
INDUSTRY
Strategic
selection
of essential medical productsPricing of local products that governments & people can afford.Strict compliance to quality standards Effective NRAs.Health securityInnovation.
Government Support
Direct
support to reduce the cost of manufacture
Indirect support of local production for improving accessSlide6
Pre-requisites for strengthening pharmaceutical manufacturing
Government political and financial commitment
Vision and coherent policy frameworkWith clear
health and industrial policy objectivesDevelopment of industry overtime along the value chain
Time-bound action planGMP roadmap and political guts to follow-upTime-bound government incentive packageOngoing monitoring and evaluationSlide7
Work with AUC and Interagency collaboration for pharmaceutical manufacturing in Africa:
WHO is supporting development of Collaborative Framework for development partners to work with AUC & NEPAD in implementation of PMPA
Current partners include: UNAIDS, WHO, UNFPA, UNDP, UNECA, USP, ANDI, FAPMA,
ADB, coordinated through UNIDO
A multi-year workplan is being developedWHO is supporting PMPA Technical Committee Meeting in NovemberSlide8
10 Year National Strategy & 5 Year Plan of Action for Pharmaceutical Manufacturing Development in Ethiopia
Ministry of Health and Ministry of Industry are equal partners
The strategy and plan of action is directly feeding into next 5 year national development plan (GTP II 2015-20) and new Health Sector Transformation Plan
a comprehensive, visionary and ambitious program to transform the pharmaceutical sector in
the country. The vision is to progressively move pharmaceutical companies along the value chain and the goal is to achieve a vertically integrated, GMP compliant and R&D based pharmaceutical sector by 2025.The government is recommended to provide a well spelled-out and time-bound incentives package to pharmaceutical companies Slide9
10 Year National Strategy & 5 Year Plan of Action for Pharmaceutical Manufacturing Development in Ethiopia - II
Some key targets include e.g.
by 2020, 60% local needs of essential medicines will be met by locally produced medicines; there
will be 8 to 10 new joint ventures; all companies will be fully GMP compliant by 2018;
there will be at least 1 API manufacturing unit in place; exports of pharmaceuticals will be in excess of USD 30 million; there will be at least 200 trained professionals in industrial pharmacy and regulatoryThe Prime Minister of Ethiopia and WHO DG will be launching the S&PA during the UN Financing for Development Conference in Addis
Ababa. Slide10
Thank you
For More Information and Accessing Publications:
http://www.who.int/phi/publications/local_production/en
/